Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Exp Allergy ; 29(12): 1671-80, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10594544

ABSTRACT

BACKGROUND: Influx of eosinophils into the post-capillary bronchial epithelium and the subsequent release of inflammatory mediators is characteristic of the late phase of asthmatic attacks. The genes that serve to predispose the peripheral blood eosinophils of asthmatics to undergo this process are poorly defined. The aim of this report is to describe the differential gene expression of both the known pro-inflammatory genes 5-lipoxygenase and 5-lipoxygenase-activating protein (FLAP) and novel cDNA sequences in eosinophils derived from clinical samples. METHODS: Novel cDNA sequences representing genes upregulated in peripheral blood eosinophils of asthmatic as compared with nonasthmatic patients were identified by differential display polymerase chain reaction (DDPCR). The differential expression of these sequences, in addition to known pro-inflammatory genes, were then studied by reverse dot blotting of amplified RNA generated from the eosinophils of nonasthmatic donors, asthmatic donors, asthmatic donors taking steroids, interleukin (IL) -3, IL-5, granulocyte-macrophage colony stimulating factor- (GM-CSF) treated eosinophils from asthmatic donors and the eosinophilic cell line AML14. RESULTS: Four unique DDPCR-generated 3'UTR DNA fragments were identified that showed differing patterns of expression between the eosinophil populations of interest. Expression of each of the novel clones was increased in the peripheral blood eosinophils of asthmatics and downregulated in those donors taking steroids. Expression of 5-lipoxygenase was not found to vary between the different eosinophil populations, whereas FLAP was induced by treatment with the cytokine cocktail in both primary eosinophils and the eosinophilic cell line AML14. CONCLUSION: The differential regulation of the novel cDNA sequences and FLAP in the range of eosinophil populations studied suggest that they may provide clinically relevant therapeutic targets. Moreover, the procedures used in these studies may provide a general approach to the study of differential gene expression in small numbers of cells such as those obtained from clinical samples.


Subject(s)
Arachidonate 5-Lipoxygenase/genetics , Asthma/blood , Carrier Proteins/genetics , Eosinophils/metabolism , Membrane Proteins/genetics , 5-Lipoxygenase-Activating Proteins , Adult , Arachidonate 5-Lipoxygenase/metabolism , Base Sequence , Carrier Proteins/metabolism , DNA, Complementary/genetics , Eosinophils/enzymology , Gene Expression Profiling , Gene Expression Regulation , Humans , Immunoblotting , Membrane Proteins/metabolism , Middle Aged , Molecular Sequence Data , Polymerase Chain Reaction/methods , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Analysis, DNA , Transcription, Genetic
2.
J Neurochem ; 73(5): 1859-70, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10537044

ABSTRACT

A thermosensitive mutation of simian virus 40 large T antigen (LTA) gene, the tsA58 gene, was cloned downstream of the 6-kbp neurofilament light chain promoter in pPOLYIII and injected into the pronucleus of fertilised oocytes of Sprague-Dawley rats to develop a strain harbouring six copies of the transgene. Immunocytochemical staining of hemizygous adult tissues with antibodies to the C-terminus of LTA showed that the inactive form of LTA was expressed only in the fibres of the internal capsule and in the choroid plexus of the brain. Culturing the former region at 33 degrees C, the permissive temperature for LTA, yielded a cell line, NF2C, which produced active LTA and grew at 33 degrees C but which produced only inactive LTA and eventually died at the non-permissive temperature of 39 degrees C. This clonal cell line was heterogeneous at 33 degrees C, producing the precursor neuronal cell marker nestin and the glial-specific markers glial fibrillary acidic protein, vimentin and S100A1, as well as weakly producing the neuronal cell markers 68-kDa neurofilament protein (NF68) and microtubule-associated protein 2 (MAP2) in different subpopulations of cells. However, at 39 degrees C, the cells produced dendritic, neuronal-like processes and elevated levels of NF68 and MAP2, as well as the neuronal markers synaptophysin, neurone-specific enolase, and low levels of tau, all determined by western blotting and immunofluorescent staining. Basic fibroblast growth factor enhanced the growth of the cells at 33 degrees C but also enhanced the formation of dendritic neuronal-like processes at 39 degrees C. It is suggested that NF2C represents a potential stem cell line from adult brain that expresses precursor and glial cell markers at 33 degrees C but undergoes partial differentiation to a neuronal cell phenotype at 39 degrees C.


Subject(s)
Brain/cytology , Cell Separation , Stem Cells/cytology , Animals , Animals, Genetically Modified , Antigens, Polyomavirus Transforming/genetics , Brain/metabolism , Cell Division , Cell Line , Gene Expression , Intermediate Filament Proteins/analysis , Intermediate Filament Proteins/biosynthesis , Mutation , Nerve Tissue Proteins/analysis , Nerve Tissue Proteins/biosynthesis , Neuroglia/cytology , Neuroglia/metabolism , Neurons/cytology , Neurons/metabolism , Rats , Rats, Sprague-Dawley , Stem Cells/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...